Moderate-to-severe Crohn's disease usually needs more than dietary changes or occasional treatment for symptoms. When intestinal inflammation is significant, persistent, or associated with complications, treatment needs to control the disease itself before repeated inflammation causes permanent bowel damage.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Modern treatment may involve:
- Short-term corticosteroids for selected active flares
- Biologic medicines
- Targeted oral therapy
- Immunomodulators in selected situations
- Nutritional support
- Endoscopic treatment for certain strictures
- Surgery when structural complications develop
The important change in modern Crohn's care is that advanced treatment does not always have to wait until several older medicines have failed. For patients with moderate-to-severe or higher-risk Crohn's disease, earlier biologic or targeted therapy may offer better control of inflammation and reduce the opportunity for progressive bowel damage.
For a broader overview of the condition and its long-term care, see our main guide to Crohn's Disease Management.
What Does Moderate-to-Severe Crohn's Disease Mean?
Crohn's disease severity is not determined by one symptom alone. A person does not necessarily have severe disease simply because abdominal pain feels severe, and someone with relatively manageable symptoms may still have significant inflammation.
Doctors consider the overall picture, including:
- Frequency and severity of diarrhoea
- Abdominal pain
- Weight loss
- Fever or systemic illness
- Anaemia or nutritional problems
- CRP and fecal calprotectin levels
- Colonoscopy findings
- MR enterography, intestinal ultrasound, or other imaging
- Deep intestinal ulcers
- Extent of bowel involvement
- Fistulas or abscesses
- Strictures
- Previous hospitalisation or surgery
- Repeated need for corticosteroids
What Is the Goal of Treatment?
For moderate-to-severe Crohn's disease, simply reducing diarrhoea or pain is not enough. Treatment aims to achieve:
- Rapid control of active inflammation
- Steroid-free clinical remission
- Objective improvement in intestinal inflammation
- Long-term maintenance of remission
- Prevention of strictures, fistulas, and abscesses
- Reduced hospitalisation and surgery where possible
- Improved nutritional status
- Better quality of life
A treatment may therefore be considered successful only when symptoms improve and there is evidence that the inflammatory disease is being adequately controlled.
Modern Treatment Has Moved Beyond the Traditional Step-Up Approach
In the past, Crohn's treatment often followed a strict sequence: Steroids → immunomodulators → biologics only after those treatments failed. This is no longer the preferred approach for every patient with moderate-to-severe disease.
Current American guidelines support starting effective advanced therapy earlier rather than requiring patients to fail medicines such as thiopurines or methotrexate first. This is especially relevant when the patient has:
- Moderate-to-severe active inflammation
- Extensive disease
- Deep ulcers
- Perianal or internal fistulas
- Previous bowel damage
- High risk of disease progression
- Steroid-dependent disease
Step 1: Control Active Inflammation
When moderate-to-severe Crohn's disease is actively flaring, doctors first need to bring the inflammation under control. This stage is called induction of remission.
Systemic Corticosteroids
Medicines such as prednisone can rapidly reduce active inflammation and are still useful for selected patients with moderately or severely active Crohn's disease. However, steroids have a very specific role: They are short-term induction medicines, not long-term maintenance treatment.
Current ACG guidance recommends limiting systemic corticosteroid exposure and transitioning rapidly to a steroid-sparing treatment. Repeated or prolonged steroid use can increase the risk of:
- Serious infections
- Osteoporosis
- High blood sugar
- High blood pressure
- Cataracts
- Weight gain
- Mood and sleep disturbances
Do You Have to Take Steroids Before Starting a Biologic?
No. Not every patient must first complete a course of steroids before starting advanced therapy. In some patients with moderate-to-severe or high-risk Crohn's disease, a biologic or other advanced treatment may be started directly.
In other situations, corticosteroids are used briefly as a bridge while the longer-term treatment begins working. The decision depends on disease severity, previous treatment, complications, and how quickly inflammation needs to be controlled.
Step 2: Start an Effective Advanced Therapy
Advanced treatments target specific inflammatory pathways responsible for Crohn's disease. Current options include several different classes.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
| Treatment Class | Examples | Main Target |
|---|---|---|
| Anti-TNF medicines | Infliximab, adalimumab, certolizumab pegol | Tumour necrosis factor |
| Anti-integrin therapy | Vedolizumab | Movement of inflammatory cells into the intestine |
| IL-12/23 inhibitor | Ustekinumab | Interleukin-12 and interleukin-23 pathway |
| Selective IL-23 inhibitors | Risankizumab, guselkumab, mirikizumab | Interleukin-23 pathway |
| JAK inhibitor | Upadacitinib | Intracellular inflammatory signalling |
Treatment for Fistulizing Crohn's Disease
Fistulas require a somewhat different strategy from uncomplicated intestinal Crohn's disease. A fistula is an abnormal connection between the intestine and another structure or the skin. Perianal fistulas may cause:
- Pain around the anus
- Persistent drainage
- Swelling
- Repeated abscesses
What If Crohn's Disease Has Caused a Stricture?
A stricture is a narrowed section of bowel. Treatment depends on whether the narrowing is caused mainly by:
- Active inflammation
- Permanent scar tissue
- A mixture of both
Inflammatory Narrowing
Effective Crohn's medication may reduce narrowing when active inflammation is the main cause.
Fibrotic Narrowing
Advanced medicines cannot dissolve mature scar tissue. A short, accessible stricture may sometimes be treated with endoscopic balloon dilation. Other strictures may require:
- Strictureplasty
- Surgical bowel resection
Repeated vomiting, severe abdominal swelling, intense cramping, or inability to pass stool or gas may indicate obstruction and requires urgent medical assessment.
When Is Surgery Needed for Moderate-to-Severe Crohn's Disease?
Surgery should not automatically be viewed as the final option after every possible medicine has failed. Sometimes structural bowel damage is better treated surgically than by repeatedly changing medication. Surgery may be needed for:
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
- Fibrotic intestinal obstruction
- Abscesses
- Complex fistulas
- Life-threatening bleeding
- Dysplasia or colorectal cancer
- Localised disease that remains uncontrolled despite appropriate medical therapy
What Tests Are Needed Before Starting Advanced Treatment?
Because biologics and targeted treatments alter immune function, pretreatment assessment is important. Depending on the medicine and individual risk, testing may include:
- Tuberculosis screening
- Hepatitis B testing
- Complete blood count
- Liver function tests
- Kidney function where relevant
- Review of previous infections
- Vaccination history
A Practical Treatment Pathway
| Clinical Situation | Typical Treatment Direction |
|---|---|
| Moderate-to-severe active Crohn's, no previous advanced therapy | Early effective biologic therapy such as anti-TNF, vedolizumab, ustekinumab, or an IL-23 inhibitor |
| Severe inflammatory flare needing rapid control | Short-term corticosteroid therapy may be used while transitioning to steroid-sparing treatment |
| Previous anti-TNF treatment failure | Consider another evidence-supported mechanism such as IL-23 therapy, ustekinumab, mirikizumab, or upadacitinib depending on the individual case |
| Perianal fistulizing disease | Infliximab or another appropriate advanced therapy plus surgical assessment when required |
| Abscess | Antibiotics and drainage before or alongside an appropriate Crohn's treatment plan |
| Inflammatory stricture | Effective medical control of inflammation may help |
| Fibrotic stricture causing obstruction | Endoscopic dilation or surgery may be required |
| Repeated steroid dependence | Reassess and optimise steroid-sparing advanced therapy |
The Bottom Line
Moderate-to-severe Crohn's disease usually requires effective treatment that directly controls intestinal inflammation. The modern approach is no longer to make every patient work slowly through conventional medicines before receiving a biologic.
Current guidelines support earlier advanced therapy when disease severity or risk justifies it. Available treatments include anti-TNF medicines such as infliximab and adalimumab, vedolizumab, ustekinumab, selective IL-23 inhibitors such as risankizumab, guselkumab and mirikizumab, and the oral JAK inhibitor upadacitinib in appropriate patients.
Corticosteroids remain useful for short-term control of selected active flares, but the aim should be to transition rapidly to a treatment capable of maintaining steroid-free remission. Previous treatment exposure matters. A patient who has never received an advanced therapy may have a different preferred treatment from someone whose Crohn's disease has already failed an anti-TNF medicine.
Complications must also be treated separately. An abscess may need drainage, a fistula may require combined medical and surgical management, and a fibrotic stricture may ultimately require endoscopic treatment or surgery because medicines cannot remove mature scar tissue.
Most importantly: The best treatment strategy is not simply the medicine that controls today's symptoms. It is the strategy most likely to achieve sustained steroid-free remission, control objective inflammation, and protect the bowel from future irreversible damage.
